Newland Pharmaceutical Co Ltd
SZSE:301277
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Newland Pharmaceutical Co Ltd
Total Equity
Newland Pharmaceutical Co Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
Newland Pharmaceutical Co Ltd
SZSE:301277
|
Total Equity
¥1.5B
|
CAGR 3-Years
56%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Total Equity
¥35.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Total Equity
¥61.3B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
19%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Total Equity
¥40B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
12%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Total Equity
¥32.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
17%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Total Equity
¥3.9B
|
CAGR 3-Years
127%
|
CAGR 5-Years
56%
|
CAGR 10-Years
N/A
|
|
Newland Pharmaceutical Co Ltd
Glance View
Newland Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Xuchang, Henan and currently employs 800 full-time employees. The company went IPO on 2022-11-16. Newland Pharmaceutical Co Ltd, formerly Henan Newland Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical research and development. The firm's main business is the research and development, production and sales of pharmaceutical intermediates. The firm's main products are L-p-hydroxyphenylglycine series products and p-toluenesulfonic acid, including D-acid, methyl ester and hydroxydeng salt. The firm also produces pharmaceutical resolution agents. The firm mainly operates its businesses in the domestic and overseas markets.
See Also
What is Newland Pharmaceutical Co Ltd's Total Equity?
Total Equity
1.5B
CNY
Based on the financial report for Dec 31, 2024, Newland Pharmaceutical Co Ltd's Total Equity amounts to 1.5B CNY.
What is Newland Pharmaceutical Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
52%
Over the last year, the Total Equity growth was 7%. The average annual Total Equity growth rates for Newland Pharmaceutical Co Ltd have been 56% over the past three years , 52% over the past five years .
